STING, having
generated significant interest within the medical research community, is
currently considered one of the fastest growing areas of cancer immunotherapy
and is being pursued by several large pharmaceutical companies
Roots Analysis is pleased to
announce the publication of its recent study, titled, “STING
Pathway Targeting Therapeutics and Technologies,
2020-2030.”
The report features an extensive study of the current market
landscape and future potential of these therapeutics and affiliated
technologies, over the next decade. This study focuses specifically on small
molecule STING modulators. The report features an in-depth analysis,
highlighting the diverse capabilities of stakeholders engaged in this domain.
In addition to other elements, the study includes:
§
A detailed assessment
of the current market landscape of therapeutics targeting STING Pathway.
§
A detailed assessment
of the current market landscape of various technology platforms that are being
actively used for the development of STING modulators.
§
Detailed profiles of
developers of therapeutics targeting STING pathway (shortlisted on the
basis of phase of development of pipeline products).
§
An in-depth analysis
of more than 280 grants that have been awarded to research institutes engaged
in STING pathway targeting therapeutics-related projects.
§
An analysis of the
initiatives of big pharma players engaged in this domain.
§
An analysis of the
start-ups / small players (established in the last ten years, less than 50
employees) engaged in the development of STING pathway targeting
therapeutics.
§
A detailed
publication analysis of more than 300 peer-reviewed, scientific articles that
have been published during the period 2019 - Q1 2020.
§
An analysis of the
partnerships that have been established in this domain, in the recent past.
§
An analysis of the
investments made in this domain.
§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
§
Types of Payment
§
Upfront Payments
§
Milestone Payments
§
Type of STING
Modulator
§
Agonist
§
Antagonist
§
Key Therapeutic
Area(s)
§
Oncological Disorders
§
Inflammatory
Disorders
§
Infectious Diseases
§
Others
§
Route of
Administration
§
Intratumoral
§
Intravenous
§
Oral
§
Subcutaneous
§
Others
§
Type of Molecule
§
Non-nucleotide
§
Cyclic Dinucleotide
§
Live Biotherapeutics
§
Oncolytic Peptides
§
Synthetic Peptides
§
Others
§
Key Geographical
Regions
§
North America
§
Europe
§
Asia-Pacific
Key
companies covered in the report
§
Aduro Biotech
§
Bristol Myers Squibb
§
Eisai
§
GlaxoSmithKline
§
ImmuneSensor Therapeutics
§
Merck
§
Noxopharm
§
Spring Bank Pharmaceuticals
§
Synlogic
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html
Other Recent
Offerings
1. Nuclear Medicine and
Radiopharmaceuticals Manufacturing Market, 2020-2030
2.
Global
Psychedelic Therapeutics Market by Type of
Psychedelic Substance (Ketamine, Psilocybin, MDMA and Others), by Origin
(Natural and Synthetic), by Type of Therapy (Monotherapy, Combination and
Others), by Route of Administration (Oral, Intravenous, Intranasal and Others)
and by Key Geographies (North America, Europe and Asia- Pacific and rest of the
world): Industry Trends and Global Forecasts, 2020-2030
3.
Endocannabinoid
System Targeted Therapeutics Market, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
